Steve Tregay
General Partner at Mission BioCapital
Cambridge, Massachusetts
Overview
Work Experience
Managing General Partner
2019 - Current
Mission BioCapital is a life science venture capital firm that invests in early-stage companies.
Raised $11,000,001.00.
Founder, Interim CEO
2020
Accelerating Unique and Transformative Neuroscience
Board Member
2020
Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.
Raised $98,000,000.00 from Octagon Capital Advisors, Retinal Degeneration Fund, Casdin Capital, Atlas Venture, Samsara BioCapital, Mission BioCapital, Foundation Fighting Blindness, Atlas Venture and Mission BioCapital.
Board Observer
2021
Nocion Therapeutics is a developer of novel pharmaceuticals intended to treat the conditions arising from neurogenic inflammation.
Raised $110,999,994.00 from Arkin Holdings, Mission BioCapital, F-Prime Capital, OUP (Osage University Partners), Canaan Partners, Monograph Capital and Mass General Brigham Ventures.
Founder, President and CEO
2008 - 2019
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Raised $142,500,000.00 from Baker Brothers Advisors LLC, RA Capital Management, Samsara BioCapital, Janus Henderson Investors, Wellington Management and Cormorant Asset Management.
Founder and Chairman of the Board of Directors
2015 - 2019
Compass Therapeutics is a biopharmaceutical company that focuses on drugging the immune system to treat human diseases.
Raised $381,512,210.00 from Dafna Capital Management, Vivo Capital, Monashee Investment Management, Braidwell, OrbiMed, Adage Capital Management, Enavate Sciences and Janus Henderson Investors.
Managing Director
2006 - 2009
Executive Director
2004 - 2006
Head of Strategic Alliances, Oncology, Ophthalmology, and Technologies
Business Development
2001 - 2004